Future directions in the surgical management of ovarian cancer
- 1 August 2003
- journal article
- review article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 90 (2), S33-S39
- https://doi.org/10.1016/s0090-8258(03)00342-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Survival and Reproductive Function After Treatment of Malignant Germ Cell Ovarian TumorsJournal of Clinical Oncology, 2001
- Optimal Cytoreductive Surgery Is an Independent Prognostic Indicator in Stage IV Epithelial Ovarian Cancer with Hepatic MetastasesGynecologic Oncology, 2000
- Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumorsCancer, 2000
- Splenectomy as Part of Cytoreductive Surgery for Ovarian CarcinomaGynecologic Oncology, 1995
- The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian CancerNew England Journal of Medicine, 1995
- The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1994
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- Resection of diaphragmatic peritoneum and muscle: Role in cytoreductive surgery for ovarian cancerGynecologic Oncology, 1989
- A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group studyCancer, 1986
- The changing prognosis and treatment in cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1968